A.P. Moller Holding rejects future life science investments despite record-breaking purchase

In spite of the fact that A.P. Moller Holding announced its biggest acquisition ever on Friday, purchasing laboratory diagnostics firm Unilabs, the rest of the industry should not hold its breath over a similar investment. "We are not currently working on life science investments," says A.P. Moller Holding's CIO.

Jan T. Nielsen, CIO at A.P. Moller Holding | Photo: A.P. Møller Holding / PR

On Friday, A.P. Moller Holding revealed plans pertaining to the acquisition of laboratory diagnostics firm Unilabs. However, the arrival of the major investment firm does not herald change for the life science industry.

According to Chief Investment Officer at A.P. Moller Holding Jan T. Nielsen, Unilabs's infrastructure – not the life science industry itself – was what drew the firm's attention.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs